Screening accuracy of Single-Point Insulin Sensitivity Estimator (SPISE) for metabolic syndrome: a systematic review and meta-analysis
Abstract Background Metabolic syndrome (MetS) is a multifactorial condition linked to increased risk of cardiovascular disease and type 2 diabetes. The Single-Point Insulin Sensitivity Estimator (SPISE), a non-invasive index calculated via 600 × HDL-C^0.185 / (TG^0.2 × BMI^1.338), offers a practical...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2025-06-01
|
| סדרה: | BMC Endocrine Disorders |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12902-025-01957-6 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
